CHÉOS Scientists are testing the cost-effectiveness of a new blood test that aims to avoid the unnecessary health complications and costs of current methods
From being asymptomatic to developing life-threatening symptoms, it’s become clear that people infected with COVID-19 respond to the virus with vastly different degrees of severity.
A recent study shows that some people may still be able to hear while in an unresponsive state at the end of their life.
Almost overnight, this researcher dropped her thesis work and pivoted all her attention to SARS-CoV-2.
Kidney Check is a screening, triage and treatment program for Indigenous communities in rural or remote parts of Canada, including British Columbia.
The World Health Organization (WHO) commissioned the study, hoping to get clarity so it could prepare recommendations.
In response to the ongoing COVID-19 situation, Providence Health Care Research Institute (PHCRI) will commence a gradual, phased resumption of research at Providence Health Care (PHC) by following the guidelines set out by the BC Public Health Officer and the principles, prioritization and contextual information set out by UBC. The approach, however, will also be aligned with PHCRI and PHC requirements.
As part of a Digital Technology Supercluster pilot project, 50 handheld ultrasound scanners are being distributed to physicians in rural areas around the province.
Data analysis experts at the PROOF (Prevention of Organ Failure) Centre played a central role in a new study that found a readily available antiviral drug could be used to treat COVID-19.
In accordance with guidance from the Provincial Health Officer, UBC will be extending its curtailment of research activities until April 30, 2020. PHCRI will adopt the same extension deadline.